glp 1 agonist vision loss GLP-1 Receptor Agonists and risk Researchers Find Small Increased Risk
Description
The GLP-1 pathway also connects to broader hormonal systems that researchers studying pancreatic peptide hormones will recognize
doi:10.2337/db18-0317 12
doi: 10.2337/db09-1694 26 HoganAETobinAMAhernTCorriganMAGaoatsweGJacksonRet al
doi: 10.3109/07420528.2014.897711 29 MochelJPDanhofM
GLP-1 receptor agonist sales growth rates are around 50% a year for diabetes treatment, but much higher for the new classes of obesity-optimised GLP-1 receptor agonists
2024;4(1) doi: 10.1530/EO-23-0015
